By By Cecilia Butini
Novartis AG on Wednesday posted lower sales and profit as it took a hit from generic medicines competition and higher restructuring costs, but increased its dividend for 2022.
The Swiss pharma major posted net profit of $1.47 billion, down from $16.31 billion the year prior, when it benefited from the sale of its investment…
What's your reaction?
Excited
0
Happy
0
In Love
0
Not Sure
0
Silly
0
